Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

Wagih Aclimandos, SOE 2019 – Updates and aims for SOE

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jun 13th 2019

Wagih Aclimandos, the new SOE President, explains the roles of the SOE / EBO / UEMS, and gives us a summary of the past, present and future of the SOE.

Questions:
1. Can you explain where the SOE fits within European Ophthalmology? (0:04)
2. What are the key updates from SOE since the 2017 meeting? (2:45)
3. As the incoming president, what are the aims over the next few years? (3:47)
4. Have you got a message for young ophthalmologists in europe? (5:43)

Filmed in partnership with the European Society of Ophthalmology (SOE) at the SOE 2019 meeting in Nice, France.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup